Walgreens Boots Alliance Inc
NASDAQ:WBA

Watchlist Manager
Walgreens Boots Alliance Inc Logo
Walgreens Boots Alliance Inc
NASDAQ:WBA
Watchlist
Price: 11.98 USD
Market Cap: 10.4B USD

Intrinsic Value

The intrinsic value of one WBA stock under the Base Case scenario is 31.91 USD. Compared to the current market price of 11.98 USD, Walgreens Boots Alliance Inc is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

WBA Intrinsic Value
31.91 USD
Undervaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Walgreens Boots Alliance Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about WBA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is WBA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Walgreens Boots Alliance Inc.

Explain Valuation
Compare WBA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Mounting competition from e-pharmacies and large retailers (e.g., Amazon, Walmart) is pressuring Walgreens Boots Alliance’s traditional brick-and-mortar model, threatening to erode both prescription volume and front-end retail sales.

Walgreens’ heavy exposure to government reimbursement and the complex regulatory environment in both the U.S. and international markets could further compress margins as payers push for lower drug prices and reduced pharmacy dispensing fees.

Ongoing cost-cutting measures and store optimization efforts may stifle near-term growth if they disrupt customer convenience or weaken the in-store experience, undermining the company’s brand power and patient loyalty.

Bull Theses

Walgreens’ strong brand recognition and expansive store footprint in key markets (the U.S. and United Kingdom) position it as a trusted pharmacy destination, enabling the company to capture prescriptions and front-end sales despite competitive pressures.

Investments in VillageMD, Shields Health Solutions, and other healthcare service ventures broaden Walgreens’ offerings beyond retail dispensing, potentially driving higher-margin services and recurring patient engagement over the long run.

Expansion of digital capabilities, including online prescription fulfillment and same-day delivery, could help Walgreens capture online market share and integrate seamlessly with its extensive physical presence, reinforcing customer loyalty.

Show More Less
How do you feel about WBA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Walgreens Boots Alliance Inc

Current Assets 15.7B
Cash & Short-Term Investments 830m
Receivables 6.6B
Other Current Assets 8.3B
Non-Current Assets 53.7B
Long-Term Investments 1.3B
PP&E 27.8B
Intangibles 22.7B
Other Non-Current Assets 2B
Current Liabilities 26B
Accounts Payable 13.6B
Accrued Liabilities 11.6B
Other Current Liabilities 738m
Non-Current Liabilities 36.3B
Long-Term Debt 7.8B
Other Non-Current Liabilities 28.4B
Efficiency

Free Cash Flow Analysis
Walgreens Boots Alliance Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Walgreens Boots Alliance Inc

Revenue
154.6B USD
Cost of Revenue
-128.1B USD
Gross Profit
26.5B USD
Operating Expenses
-23.1B USD
Operating Income
3.4B USD
Other Expenses
-9.7B USD
Net Income
-6.3B USD
Fundamental Scores

WBA Profitability Score
Profitability Due Diligence

Walgreens Boots Alliance Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Operating Margin is Increasing
35/100
Profitability
Score

Walgreens Boots Alliance Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

WBA Solvency Score
Solvency Due Diligence

Walgreens Boots Alliance Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Average Altman Z-Score
Long-Term Solvency
Average D/E
Short-Term Solvency
35/100
Solvency
Score

Walgreens Boots Alliance Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WBA Price Targets Summary
Walgreens Boots Alliance Inc

There are no price targets for WBA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for WBA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

WBA Insider Trading
Buy and sell transactions by insiders

WBA News

Other Videos
What is the Intrinsic Value of one WBA stock?

The intrinsic value of one WBA stock under the Base Case scenario is 31.91 USD.

Is WBA stock undervalued or overvalued?

Compared to the current market price of 11.98 USD, Walgreens Boots Alliance Inc is Undervalued by 62%.

Back to Top